Send feedback

GPHN p.Ser663Pro

c.1987T>C · rs762085852 · VCV1444945

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
AlphaMissense
likely pathogenic
0.9985 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000766%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
sulfite oxidase deficiency due to molybdenum cofactor deficiency type C

Computational evidence

Protein change
AlphaMissense0.9985likely pathogenic
REVEL0.92moderately pathogenic-leaning
SaProtLLR -11.84damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.8GERP 2.3, phastCons 1
Regional constrainto/e 0.68unconstrained · MANE · 110 kb · p 7.9e-10 · regional, not allelic
Overall
CADD31.0PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM S630P vs ClinVar S663P) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000766% European (non-Finnish) · 9/1,174,784 alleles
Filtering AF 0.00036% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000261%
Overall 0.000995% 16/1,608,428 alleles · very rare exomes 16/1,456,112 · genomes 0/152,316 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.00781% 12,804
Remaining individualsnot grpmax-eligible 0.00321% 31,151
European (non-Finnish)grpmax 0.000766% 130,532

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
GPHN
Protein
p.Ser663Pro
Coding
c.1987T>C
MANE Select
NM_020806
dbSNP
rs762085852
Type
single nucleotide variant
Location
chr14:67168944 (GRCh38)
Gene constraint
LOEUF 0.24 · pLI 1.00 · ClinGen HI 1/3 (gnomAD)
Structure
AlphaFold pLDDT 84.15 · 1 PDB
Residue 630 UniProt numbering
the 'mpt adenylyltransferase' region
Full GPHN gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gphn-p-ser663pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown